Skip to main content
lexblog.com/lib/GG0SCV1Xviewrecordjson
LEX-WK-GG0SCV1Xcrawled 2022-07-22 13:51Z

FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency

John D. Kendzior · Ryan Pate · Health Industry Washington Watch · Published June 19, 2020

Work details

firm or organization
Reed Smith LLP
published
2020-06-19

Citation

John D. Kendzior, Ryan Pate, FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency, Health Industry Washington Watch (June 19, 2020) [The Library at LexBlog, LEX-WK-GG0SCV1X, lexpid.org/GG0SCV1X]